Eric Joseph Daniels - 21 Oct 2021 Form 3 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role: Chief Development Officer
Signature: /s/ Sarah Romano, attorney-in-fact
Issuer symbol: KPRX
Transactions as of: 21 Oct 2021
Net transactions value: $0
Form type: 3
Filing time: 10 Nov 2021, 15:15:33 UTC
Next filing: 03 Feb 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney